Coeptis Therapeutics Holdings, Inc. (COEP)
NASDAQ: COEP · Real-Time Price · USD
12.60
+0.10 (0.80%)
At close: Sep 17, 2025, 4:00 PM EDT
12.50
-0.10 (-0.79%)
After-hours: Sep 17, 2025, 7:42 PM EDT
COEP Market Cap
COEP has a market cap or net worth of $60.74 million as of September 17, 2025. Its market cap has increased by 672.30% in one year.
Market Cap
60.74M
Enterprise Value
59.47M
1-Year Change
672.30%
Ranking
Category
Stock Price
$12.60
Market Cap Chart
Since December 17, 2020, COEP's market cap has decreased from $328.44M to $60.74M, a decrease of -81.51%. That is a compound annual growth rate of -29.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 60.25M | 432.86% |
| Dec 31, 2024 | 11.31M | -57.71% |
| Dec 29, 2023 | 26.74M | -10.53% |
| Dec 30, 2022 | 29.89M | -98.80% |
| Dec 31, 2021 | 2.49B | 637.84% |
| Dec 31, 2020 | 338.06M | 2.93% |
| Dec 17, 2020 | 328.44M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 686.51B |
| Johnson & Johnson | 424.98B |
| AbbVie | 382.04B |
| UnitedHealth Group | 307.73B |
| Novo Nordisk | 253.09B |
| AstraZeneca | 240.11B |
| Novartis AG | 237.94B |
| Abbott Laboratories | 231.06B |